COSMOS Pharmaceutical Corporation (TYO:3349)
Japan
· Delayed Price · Currency is JPY 6,846.00
+335.00 (5.15%)
At close: Mar 9, 2026
COSMOS Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | 2020 - 2016 |
| Market Capitalization | 542,595 | 700,001 | 502,890 | 525,081 | 483,107 | 603,094 | Upgrade
|
| Market Cap Growth | -4.12% | 39.20% | -4.23% | 8.69% | -19.89% | -1.55% | Upgrade
|
| Enterprise Value | 539,455 | 705,765 | 495,143 | 507,058 | 456,292 | 562,389 | Upgrade
|
| Last Close Price | 6846.00 | 8788.16 | 6258.96 | 6484.39 | 5923.09 | 7353.20 | Upgrade
|
| PE Ratio | 17.39 | 22.60 | 20.57 | 22.07 | 20.86 | 22.21 | Upgrade
|
| Forward PE | 16.57 | 21.94 | 19.07 | 21.97 | 19.33 | 24.17 | Upgrade
|
| PS Ratio | 0.52 | 0.69 | 0.52 | 0.63 | 0.64 | 0.83 | Upgrade
|
| PB Ratio | 2.02 | 2.72 | 2.17 | 2.49 | 2.54 | 3.54 | Upgrade
|
| P/TBV Ratio | 2.02 | 2.72 | 2.18 | 2.49 | 2.54 | 3.54 | Upgrade
|
| P/FCF Ratio | - | - | - | 67.33 | - | 333.02 | Upgrade
|
| P/OCF Ratio | 9.11 | 13.34 | 9.11 | 9.65 | 15.01 | 21.64 | Upgrade
|
| PEG Ratio | 3.50 | 1.92 | 1.92 | 1.92 | 1.92 | 1.92 | Upgrade
|
| EV/Sales Ratio | 0.52 | 0.70 | 0.51 | 0.61 | 0.60 | 0.77 | Upgrade
|
| EV/EBITDA Ratio | 8.42 | 11.27 | 9.63 | 10.68 | 10.16 | 11.98 | Upgrade
|
| EV/EBIT Ratio | 13.24 | 17.47 | 15.72 | 16.83 | 15.31 | 16.97 | Upgrade
|
| EV/FCF Ratio | -1167.65 | - | - | 65.02 | - | 310.54 | Upgrade
|
| Debt / Equity Ratio | 0.15 | 0.19 | 0.15 | 0.09 | 0.05 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 0.63 | 0.80 | 0.66 | 0.38 | 0.21 | 0.22 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 2.33 | - | 5.77 | Upgrade
|
| Net Debt / Equity Ratio | -0.01 | -0.03 | -0.08 | -0.13 | -0.15 | -0.26 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.05 | -0.11 | -0.35 | -0.58 | -0.62 | -0.95 | Upgrade
|
| Net Debt / FCF Ratio | 6.80 | 8.24 | 28.72 | -3.56 | 2.47 | -24.66 | Upgrade
|
| Asset Turnover | 2.03 | 2.02 | 2.15 | 2.11 | 2.15 | 2.20 | Upgrade
|
| Inventory Turnover | 8.50 | 8.94 | 9.49 | 9.16 | 9.52 | 10.19 | Upgrade
|
| Quick Ratio | 0.19 | 0.31 | 0.30 | 0.29 | 0.28 | 0.39 | Upgrade
|
| Current Ratio | 0.72 | 0.75 | 0.72 | 0.71 | 0.71 | 0.78 | Upgrade
|
| Return on Equity (ROE) | 12.17% | 12.67% | 11.05% | 11.85% | 12.83% | 17.17% | Upgrade
|
| Return on Assets (ROA) | 4.95% | 5.04% | 4.39% | 4.80% | 5.29% | 6.26% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.46% | 12.74% | 11.52% | 12.65% | 14.47% | 20.14% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.00% | 13.30% | 12.00% | 13.20% | 14.80% | 18.20% | Upgrade
|
| Earnings Yield | 5.75% | 4.42% | 4.86% | 4.53% | 4.79% | 4.50% | Upgrade
|
| FCF Yield | -0.09% | -0.12% | -0.13% | 1.49% | -2.34% | 0.30% | Upgrade
|
| Dividend Yield | 1.15% | 0.80% | 0.96% | 0.77% | 0.68% | 0.48% | Upgrade
|
| Payout Ratio | 17.79% | 16.01% | 19.05% | 13.72% | 14.11% | 8.38% | Upgrade
|
| Buyback Yield / Dilution | - | -0.02% | -0.05% | 0.00% | 0.00% | 0.00% | Upgrade
|
| Total Shareholder Return | 1.15% | 0.78% | 0.91% | 0.77% | 0.68% | 0.48% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.